Hsing-Chun Kuo Selected Research

2,6- dimethoxy- 1,4,5,8- phenanthrenetetrone

1/2016

Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hsing-Chun Kuo Research Topics

Disease

20	Neoplasms (Cancer) 10/2021 - 01/2006
11	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 03/2012
9	Inflammation (Inflammations) 02/2022 - 12/2003
7	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2018 - 03/2015
6	Glioma (Gliomas) 07/2014 - 12/2003
4	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 03/2005
4	Stomach Neoplasms (Stomach Cancer) 04/2021 - 06/2014
4	Carcinogenesis 07/2015 - 10/2007
3	Osteoarthritis 01/2022 - 04/2013
3	Aneurysm (Aneurysms) 08/2017 - 01/2016
3	Ischemia 01/2017 - 08/2014
3	Colonic Neoplasms (Colon Cancer) 01/2017 - 10/2007
3	Brain Injuries (Brain Injury) 03/2016 - 08/2014
3	Ischemic Stroke 05/2015 - 08/2014
3	Stroke (Strokes) 05/2015 - 08/2014
3	Neoplasm Metastasis (Metastasis) 06/2014 - 02/2008
2	Parkinson Disease (Parkinson's Disease) 02/2020 - 03/2016
2	Fibrosis (Cirrhosis) 03/2019 - 01/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 01/2016
2	Anemia 01/2018 - 05/2016
2	Obesity 09/2015 - 06/2014
2	Carcinoma (Carcinomatosis) 06/2014 - 10/2007
2	Astrocytoma (Pilocytic Astrocytoma) 11/2013 - 08/2012
1	Lymphatic Metastasis 06/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2022
1	Knee Osteoarthritis 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Liver Neoplasms (Liver Cancer) 08/2021
1	Hepatoblastoma 08/2021
1	Body Weight (Weight, Body) 03/2019
1	Alcoholic Fatty Liver 03/2019
1	Vasculitis (Vasculitides) 01/2018
1	Disease Susceptibility (Diathesis) 08/2017

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2006
8	p38 Mitogen-Activated Protein KinasesIBA 05/2015 - 12/2003
6	Intravenous Immunoglobulins (IVIG)FDA Link 08/2017 - 03/2015
5	1- (4- (furo(2,3- b)quinolin- 4- ylamino)phenyl)ethanoneIBA 01/2021 - 08/2012
5	erinacine AIBA 01/2019 - 08/2014
4	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014 - 10/2007
4	caffeic acid phenethyl esterIBA 07/2014 - 12/2003
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2015
3	CytokinesIBA 01/2022 - 09/2014
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2021 - 03/2006
3	Biological ProductsIBA 01/2021 - 12/2003
3	LigandsIBA 07/2015 - 10/2012
2	ailanthoidolIBA 05/2022 - 08/2021
2	Histones (Histone)IBA 04/2021 - 01/2019
2	Propidium (Propidium Iodide)IBA 01/2021 - 01/2017
2	AlkaloidsIBA 01/2021 - 02/2008
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2020 - 03/2016
2	AntioxidantsIBA 01/2018 - 12/2003
2	EnzymesIBA 01/2018 - 06/2014
2	HepcidinsIBA 01/2018 - 05/2016
2	InterferonsIBA 04/2016 - 12/2014
2	DiterpenesIBA 03/2016 - 08/2014
2	ResistinIBA 09/2015 - 06/2014
2	Coloring Agents (Dyes)IBA 12/2014 - 03/2006
2	3-nitrotyrosineIBA 09/2014 - 08/2014
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2014 - 08/2014
2	Propolis (Bee Bread)IBA 07/2014 - 12/2003
2	CXC ChemokinesIBA 06/2014 - 10/2012
2	Peptide Hydrolases (Proteases)FDA Link 04/2013 - 03/2012
2	baicaleinIBA 03/2012 - 09/2011
2	FlavonoidsIBA 09/2011 - 03/2005
2	BerberineIBA 02/2008 - 10/2007
1	GelsolinIBA 06/2022
1	PeroxiredoxinsIBA 06/2022
1	Dinoprostone (PGE2)FDA Link 02/2022
1	LignansIBA 08/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 08/2021
1	TNF-Related Apoptosis-Inducing LigandIBA 04/2021
1	Cyclin D1IBA 04/2021
1	erinacine SIBA 04/2021
1	Fluo-3IBA 01/2021
1	diacetyldichlorofluoresceinIBA 01/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2021
1	BromidesIBA 01/2021
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2021
1	Cyclin B1IBA 01/2021
1	Annexin A5IBA 01/2021
1	2',7'-dichlorofluoresceinIBA 01/2021
1	isothiocyanic acidIBA 01/2021
1	MethyltransferasesIBA 03/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2019
1	DNA (Deoxyribonucleic Acid)IBA 03/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Fas Ligand Protein (Fas Ligand)IBA 01/2019
1	AlbuminsIBA 08/2017
1	FITC-annexin A5IBA 01/2017

Therapy/Procedure

4	Therapeutics 08/2021 - 01/2006
2	Total Parenteral Nutrition 11/2015 - 06/2013
2	Drug Therapy (Chemotherapy) 01/2006 - 03/2005
1	Lasers (Laser) 06/2022
1	Prolotherapy 01/2022
1	Immunomodulation 10/2021
1	Oral Administration 10/2021
1	Ligation 01/2019
1	Length of Stay 08/2017